Financial reports
10-K
2023 FY
Annual report
21 Jun 23
10-Q
2023 Q3
Quarterly report
8 Feb 23
10-Q
2023 Q2
Quarterly report
9 Nov 22
10-Q
2022 Q1
Quarterly report
10 Aug 22
10-K
2022 FY
Annual report
9 Jun 22
10-Q
2022 Q3
Quarterly report
9 Feb 22
10-Q
2022 Q2
Quarterly report
10 Nov 21
10-Q
2022 Q1
Quarterly report
12 Aug 21
10-K
2021 FY
Annual report
24 Jun 21
10-Q
2020 Q3
Quarterly report
11 Feb 21
Current reports
8-K
Departure of Directors or Certain Officers
27 Jun 23
8-K
Entry into a Material Definitive Agreement
16 Jun 23
8-K
Unregistered Sales of Equity Securities
16 Jun 23
8-K
Bionik Laboratories Expands its Partnership with Lifepoint Health with the Installation of InMotion® Robotic Devices at Four New Locations
15 Jun 23
8-K
Bionik Laboratories Reports a Significant Increase in Patient Volume at its Acquired
23 May 23
8-K
Bionik Laboratories Enters into Distribution Agreement with Pro-Med Technology for the Sale of InMotion® Robotic Devices in Hong Kong
4 May 23
8-K
Entry into a Material Definitive Agreement
26 Apr 23
8-K
Entry into a Material Definitive Agreement
23 Feb 23
8-K
Bionik Laboratories Reports Third Quarter Fiscal Year 2023 Financial Results
8 Feb 23
8-K
Submission of Matters to a Vote of Security Holders
20 Jan 23
Registration and prospectus
15-12G
Securities registration termination
30 Jun 23
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Jun 23
424B3
Prospectus supplement
21 Feb 20
424B3
Prospectus supplement
18 Nov 19
S-1/A
IPO registration (amended)
12 Nov 19
S-1/A
IPO registration (amended)
11 Oct 19
S-1
IPO registration
16 Sep 19
RW
Registration withdrawal request
18 Mar 19
S-1/A
IPO registration (amended)
25 Feb 19
424B3
Prospectus supplement
15 Feb 19
Proxies
DEFA14A
Additional proxy soliciting materials
7 Dec 22
DEF 14A
Definitive proxy
7 Dec 22
DEF 14A
Definitive proxy
17 Nov 21
DEF 14A
Definitive proxy
8 Sep 20
PRE 14A
Preliminary proxy
27 Aug 20
DEF 14A
Definitive proxy
19 Dec 19
DEF 14A
Definitive proxy
11 Feb 19
DEF 14C
Information statement
17 Aug 18
PRE 14C
Preliminary information
7 Aug 18
DEF 14C
Information statement
16 May 18
Other
SD
Conflict minerals disclosure
31 May 23
SD
Conflict minerals disclosure
27 May 22
CT ORDER
Confidential treatment order
27 May 22
SD
Conflict minerals disclosure
1 Jun 21
SD
Conflict minerals disclosure
1 Jun 20
EFFECT
Notice of effectiveness
13 Nov 19
CORRESP
Correspondence with SEC
12 Nov 19
UPLOAD
Letter from SEC
8 Nov 19
CORRESP
Correspondence with SEC
5 Nov 19
UPLOAD
Letter from SEC
29 Oct 19
Ownership
4
Remi Gaston-Dreyfus
21 Jun 23
4
ANDRE-JACQUES AUBERTON-HERVE
21 Jun 23
4
Charles Matine
21 Jun 23
4
Remi Gaston-Dreyfus
21 Jun 23
4
ANDRE-JACQUES AUBERTON-HERVE
21 Jun 23
3
Daniel Gonsalves
25 Oct 22
4
Richard Paul Russo Jr
13 Oct 22
4
ANDRE-JACQUES AUBERTON-HERVE
21 Jun 22
4
Remi Gaston-Dreyfus
21 Jun 22
4
Remi Gaston-Dreyfus
13 Dec 21